Status:
UNKNOWN
Viral Infections and Airway Microbiome in Young Children With Cystic Fibrosis
Lead Sponsor:
University Hospital, Antwerp
Conditions:
Cystic Fibrosis in Children
Respiratory Bacterial Infection
Eligibility:
All Genders
Up to 5 years
Brief Summary
Cystic fibrosis (CF) is the most common hereditary life-threatening condition in Belgium. Because of a dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) channel, chloride is una...
Eligibility Criteria
Inclusion
- Diagnosis of cystic fibrosis
Exclusion
- None
Key Trial Info
Start Date :
November 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06188988
Start Date
November 1 2023
End Date
October 31 2025
Last Update
May 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Antwerp University Hospital
Edegem, Antwerp, Belgium, 2650